Wall Street is positive on NextCure Inc (NXTC). On average, analysts give NextCure Inc a Strong Buy rating. The average price target is $63.75, which means analysts expect the stock to add by 231.00% over the next twelve months.
That average ranking earns NextCure Inc an Analyst Rating of 61, which is better than 61% of stocks based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.
Investors Observer averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.
What's Happening With NextCure Inc Stock Today?
NextCure Inc (NXTC) stock is trading at $19.26 as of 10:10 AM on Wednesday, Jul 8, a rise of $0.66, or 3.55% from the previous closing price of $18.60. The stock has traded between $19.01 and $19.68 so far today. Volume today is less active than usual. So far 43,014 shares have traded compared to average volume of 470,058 shares.